Anika Therapeutics
ANIK
ANIK
120 hedge funds and large institutions have $340M invested in Anika Therapeutics in 2024 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 42 increasing their positions, 42 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
120
Holders Change
+3
Holders Change %
+2.56%
% of All Funds
1.74%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
14
Increased
42
Reduced
42
Closed
11
Calls
$469K
Puts
$160K
Net Calls
+$309K
Net Calls Change
+$327K
Top Buyers
| 1 |
CP
Caligan Partners
New York
|
$36.5M |
| 2 |
BlackRock
New York
|
$39.7M |
| 3 |
MIM
Meros Investment Management
Dallas,
Texas
|
$4.32M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
$10.7M |
| 5 |
AFA
Alta Fundamental Advisers
New York
|
$6.64M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
$17.8M |
| 2 |
Millennium Management
New York
|
$2.95M |
| 3 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
$0 |
| 4 |
Citadel Advisors
Miami,
Florida
|
$1.02M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
$3.04M |
